evolocumab
amgen
['evolocumab', 'cardio', 'amgen']
released today at #esccongress: long-term evolocumab in patients with established atherosclerotic cardiovascular disease #esc2022 #cholesterol #lipids 
Husband. Proud dad. TEDMed Champion for prevention; CEO, National Forum for Heart Disease & Stroke Prevention; adj prof, Loma Linda Univ. Tweets are my own.